CVE-2023-53734 Details
Description
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
A SQL injection vulnerability has been identified in Dawa Pharma version 1.0. This issue allows unauthenticated attackers to execute SQL queries through the email parameter, potentially accessing sensitive client information and administrative privileges on the server. The vulnerability arises from improper handling of SQL commands, enabling attackers to inject malicious payloads that are executed by the database.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
Volerion
Assessed Dec 4, 2025CISA-ADP
Assessed Dec 5, 2025References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-89 | Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| Mayuri K Dawa Pharma | All versions |
CPE
Remediation
| |
Change History
3 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Dec 4, 2025 | New CVE Received | [email protected] |
Volerion